StocksMediumUpdated×3•Originally published 3 August 2026•Updated 3 August 2026•
1 min read

US Futures Mixed Amid Yen Intervention and Asian Market Volatility

Graphic showing maps of the US and Asia, a U.S. Futures board with mixed arrows, and a Yen Intervention banner.

Key Facts

1S&P futures rose 0.5% and Nasdaq futures gained 0.4% led by Mega-cap technology stocks.
2Prysmian agreed to acquire Atkore in a cash deal valued at $3.8 billion including debt.
3Bristol-Myers Squibb shares gained 5% on reports that AstraZeneca has explored an acquisition of the company.

In a shift reflecting heightened global macro sensitivity, market sentiment is now grappling with currency interventions and regional volatility in Asia. According to reports, Japanese Yen intervention and declining oil prices have provided a floor for global equities, easing some inflationary concerns. However, this support was partially offset by unexpected headwinds stemming from significant selling pressure in South Korean markets, creating a complex backdrop for US futures.

Domestically, corporate M&A remains a key pillar of support, highlighted by Prysmian's $3.8 billion cash deal for Atkore. Per market data, MSFT traded at $476.51 and NVDA at $197.89 on August 3, 2026, while BMY shares remained in focus at $65.31 (July 31, 2026 close) following reports of potential acquisition interest from AstraZeneca.

Traders are closely monitoring technical levels for mega-cap tech, with AAPL trading at $305.23 on August 3, 2026. With the immediate economic calendar showing no major upcoming catalysts, the market's trajectory will likely depend on the continued impact of Yen stabilization and whether energy price declines can sustain current equity valuations.